279 related articles for article (PubMed ID: 25139589)
1. The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study.
Demant DT; Lund K; Vollert J; Maier C; Segerdahl M; Finnerup NB; Jensen TS; Sindrup SH
Pain; 2014 Nov; 155(11):2263-73. PubMed ID: 25139589
[TBL] [Abstract][Full Text] [Related]
2. Pain relief with lidocaine 5% patch in localized peripheral neuropathic pain in relation to pain phenotype: a randomised, double-blind, and placebo-controlled, phenotype panel study.
Demant DT; Lund K; Finnerup NB; Vollert J; Maier C; Segerdahl MS; Jensen TS; Sindrup SH
Pain; 2015 Nov; 156(11):2234-2244. PubMed ID: 26090758
[TBL] [Abstract][Full Text] [Related]
3. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
4. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study.
Dogra S; Beydoun S; Mazzola J; Hopwood M; Wan Y
Eur J Pain; 2005 Oct; 9(5):543-54. PubMed ID: 16139183
[TBL] [Abstract][Full Text] [Related]
5. Effect of lacosamide in peripheral neuropathic pain: study protocol for a randomized, placebo-controlled, phenotype-stratified trial.
Carmland ME; Kreutzfeldt M; Holbech JV; Andersen NT; Jensen TS; Bach FW; Sindrup SH; Finnerup NB
Trials; 2019 Oct; 20(1):588. PubMed ID: 31604475
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
[TBL] [Abstract][Full Text] [Related]
7. The effect of lacosamide in peripheral neuropathic pain: A randomized, double-blind, placebo-controlled, phenotype-stratified trial.
Carmland ME; Kreutzfeldt MD; Holbech JV; Brask-Thomsen PK; Krøigård T; Hansen PN; Tankisi H; Jensen TS; Bach FW; Sindrup SH; Finnerup NB
Eur J Pain; 2024 Jan; 28(1):105-119. PubMed ID: 37565715
[TBL] [Abstract][Full Text] [Related]
8. Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain.
Dellemijn PL; Vanneste JA
Lancet; 1997 Mar; 349(9054):753-8. PubMed ID: 9074573
[TBL] [Abstract][Full Text] [Related]
9. Neuropathy following spinal nerve injury shares features with the irritable nociceptor phenotype: A back-translational study of oxcarbazepine.
Patel R; Kucharczyk M; Montagut-Bordas C; Lockwood S; Dickenson AH
Eur J Pain; 2019 Jan; 23(1):183-197. PubMed ID: 30091265
[TBL] [Abstract][Full Text] [Related]
10. Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study.
Beydoun A; Shaibani A; Hopwood M; Wan Y
Acta Neurol Scand; 2006 Jun; 113(6):395-404. PubMed ID: 16674606
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of the AMPA receptor antagonist NS1209 and lidocaine in nerve injury pain: a randomized, double-blind, placebo-controlled, three-way crossover study.
Gormsen L; Finnerup NB; Almqvist PM; Jensen TS
Anesth Analg; 2009 Apr; 108(4):1311-9. PubMed ID: 19299805
[TBL] [Abstract][Full Text] [Related]
12. A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy.
Grosskopf J; Mazzola J; Wan Y; Hopwood M
Acta Neurol Scand; 2006 Sep; 114(3):177-80. PubMed ID: 16911345
[TBL] [Abstract][Full Text] [Related]
13. Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled study.
Ostenfeld T; Krishen A; Lai RY; Bullman J; Baines AJ; Green J; Anand P; Kelly M
Eur J Pain; 2013 Jul; 17(6):844-57. PubMed ID: 23239139
[TBL] [Abstract][Full Text] [Related]
14. Effect of minocycline on lumbar radicular neuropathic pain: a randomized, placebo-controlled, double-blind clinical trial with amitriptyline as a comparator.
Vanelderen P; Van Zundert J; Kozicz T; Puylaert M; De Vooght P; Mestrum R; Heylen R; Roubos E; Vissers K
Anesthesiology; 2015 Feb; 122(2):399-406. PubMed ID: 25373391
[TBL] [Abstract][Full Text] [Related]
15. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.
Backonja M; Wallace MS; Blonsky ER; Cutler BJ; Malan P; Rauck R; Tobias J;
Lancet Neurol; 2008 Dec; 7(12):1106-12. PubMed ID: 18977178
[TBL] [Abstract][Full Text] [Related]
16. Symptom-Based Treatment of Neuropathic Pain in Spinal Cord-Injured Patients: A Randomized Crossover Clinical Trial.
Min K; Oh Y; Lee SH; Ryu JS
Am J Phys Med Rehabil; 2016 May; 95(5):330-8. PubMed ID: 26368836
[TBL] [Abstract][Full Text] [Related]
17. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial.
Gilron I; Bailey JM; Tu D; Holden RR; Jackson AC; Houlden RL
Lancet; 2009 Oct; 374(9697):1252-61. PubMed ID: 19796802
[TBL] [Abstract][Full Text] [Related]
18. Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial.
Nurmikko TJ; Serpell MG; Hoggart B; Toomey PJ; Morlion BJ; Haines D
Pain; 2007 Dec; 133(1-3):210-20. PubMed ID: 17997224
[TBL] [Abstract][Full Text] [Related]
19. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.
Ho KY; Huh BK; White WD; Yeh CC; Miller EJ
Clin J Pain; 2008 Jan; 24(1):51-5. PubMed ID: 18180637
[TBL] [Abstract][Full Text] [Related]
20. Neuropathic pain: precise sensory profiling improves treatment and calls for back-translation.
Baron R; Dickenson AH
Pain; 2014 Nov; 155(11):2215-2217. PubMed ID: 25168667
[No Abstract] [Full Text] [Related]
[Next] [New Search]
